banner.png

Big Pharma M&As: Clinical Trial Data Visualization

This interactive data visualization app offers an immersive insights into the
consequences of some of the biggest mergers and acquisitions (M&As) in the pharmaceutical industry.

Users can explore the impact of M&As on pharma companies, by examining how it
affects their number of ran clinical trials, R&D spending, and share prices.

Through this app, users can gain valuable insights into how M&As shape the industry, which can enable them to make informed strategic decisions based on data-driven analysis.

Absolute number of clinical trials ran by companies before and after M&A event (includes stock price of an acquirer)

In 2015 AbbVie acquired PharmacyclicsIn 2020 AbbVie acquired Allergan

Absolute number of clinical trials ran by companies before and after M&A event (includes R&D spending of an acquirer)

In 2015 AbbVie acquired PharmacyclicsIn 2020 AbbVie acquired Allergan

Relative number of clinical trials ran by companies before and after M&A event

*year 0 represents the M&A event of each acquisition

Experience the power of data visualization with eyesON interactive visualizers.
Explore more and discover insights you never knew existed.